Related Experiment Videos
[Central ocular hypotensive effect of noradrenaline]
1Department of Ophthalmology, Showa University School of Medicine, Tokyo, Japan.
Nippon Ganka Gakkai Zasshi
|June 1, 1995
Summary
Central administration of noradrenaline (NA) lowered intraocular pressure (IOP) in rabbits, suggesting a role for alpha 2-adrenoceptors in the central nervous system. Topical NA did not affect IOP.
Area of Science:
- Ophthalmology
- Neuroscience
- Pharmacology
Context:
- Intraocular pressure (IOP) regulation is crucial for ocular health.
- Noradrenaline (NA) is a key neurotransmitter with known systemic effects.
- Understanding central nervous system (CNS) control of IOP is vital for glaucoma research.
Purpose:
- To investigate the effects of central versus topical noradrenaline (NA) administration on intraocular pressure (IOP) in pigmented rabbits.
- To elucidate the adrenoceptor subtype involved in the central hypotensive effect of NA.
Summary:
- Central administration of noradrenaline (NA) via intracerebroventricular (ICV) injection dose-dependently reduced intraocular pressure (IOP) in both eyes of pigmented rabbits.
- Topical ocular application of NA did not significantly alter IOP.
- The hypotensive effect of centrally administered NA was attenuated by superior cervical sympathectomy and pretreatment with yohimbine, an alpha 2-adrenoceptor antagonist.
Impact:
- These findings suggest that the ocular hypotensive effects of centrally administered NA are mediated through alpha 2-adrenoceptor stimulation within the central nervous system.
- This research provides insights into novel pathways for managing IOP and potential therapeutic targets for glaucoma.